awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36407477-5E72FE8C-C14D-45E3-A861-5804EC14AACD
Q36407477-5E72FE8C-C14D-45E3-A861-5804EC14AACD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407477-5E72FE8C-C14D-45E3-A861-5804EC14AACD
Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.
P2860
Q36407477-5E72FE8C-C14D-45E3-A861-5804EC14AACD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407477-5E72FE8C-C14D-45E3-A861-5804EC14AACD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6cf911fb5cc0bbad052a57f92989160aec09825
P2860
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.